Tolga Tanguler
Corporate Officer/Principal at ALNYLAM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Tolga Tanguler is currently the Chief Commercial Officer at Alnylam Pharmaceuticals, Inc. He previously worked as a Director at Ferrosan Holding A, Regional President-North America at Pfizer Inc., and Senior Vice President at Alexion Pharmaceuticals, Inc. He holds an MBA from Michigan State University and an undergraduate degree from Istanbul University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-29 | 9,987 ( 0.01% ) | 1 M $ | 2024-04-29 |
Tolga Tanguler active positions
Companies | Position | Start |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-01-04 |
Former positions of Tolga Tanguler
Companies | Position | End |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Director/Board Member | - |
Training of Tolga Tanguler
Michigan State University | Masters Business Admin |
Istanbul University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Retail Trade |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Tolga Tanguler